| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2008;51:e31.)
© 2008 American Heart Association, Inc.
Letters to the Editor |
Department of Pediatrics, Consorcio Hospital General, University of Valencia, Valencia, Spain
We welcome the interest that Perciaccante1 has shown in our research on the impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents.2 We agree with his hypothesis that abnormal cardiovascular autonomic function is a potential link between insulin resistance and increased nocturnal blood pressure. Overactivity of the sympathetic nervous system is a common feature of obesity in humans and may play an important role in the frequent association of this condition with blood pressure elevation.3 Hyperinsulinemia, however, may increase blood pressure by enhancing sodium reabsorption primarily at the distal nephron, an action that is independent of the hormonal effect on the sympathetic and renin-angiotensin-aldosterone system activities.4 This effect is clearly maintained in individuals with insulin resistance. In healthy humans, hyperinsulinemia resulted in a significant reduction of urinary sodium excretion of
50%.5 The consequent volume overload becomes more evident during nocturnal recumbence, contributing to the maintenance of an elevated sleep systolic blood pressure.
The observed relationship between insulin levels and nocturnal blood pressure in our study may result from the impact of insulin on both the autonomic and hormonal systems, as well as on primary sodium retention in the kidney.
| Acknowledgments |
|---|
This study was supported by a grant from the Department of Pediatrics, Consorcio Hospital General, University of Valencia and CIBER Fisiopatología Obesidad y Nutrición (CB06/03), Instituto de Salud Carlos III, Valencia, Spain.
Disclosures
None.
| References |
|---|
|
|
|---|
2. Lurbe E, Torro I, Aguilar F, Alvarez J, Alcon J, Pascual JM, Redon J. Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension. 2008: 51: 635–641.
3. Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, Reid J, Van Zwieten PA. The sympathetic nervous system and the metabolic syndrome. J Hypertens. 2007; 25: 909–920.[Medline] [Order article via Infotrieve]
4. Sarafidis P, Bakris G. The antinatriuretic effect of insulin: An unappreciated mechanism for hypertension associated with insulin resistance? Am J Nephrol. 2007; 27: 44–54.[CrossRef][Medline] [Order article via Infotrieve]
5. Stenvinkel P, Bolinder J, Alvestrand A. Effects of insulin on renal haemodynamics and the proximal and distal tubular sodium handling in healthy subjects. Diabetologia. 1992; 35: 1042–1048.[CrossRef][Medline] [Order article via Infotrieve]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |